Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by Redbaron2211on Nov 29, 2018 1:34pm

137 Views

Post# 29040651

Partner? I think so... Viacyte secures 100mil.

I think its starting to become clear that once we step into the big leagues and this trial gets underway there is going to be some strategic collaborations.

Viacyte secures 100mil with out showing consistent and robust engraftment.

Now what happens when sva with 35 mil market cap walks into the room?

https://viacyte.com/archives/press-releases/viacyte-secures-80-million-financing-to-advance-functional-cures-for-insulin-requiring-diabetes

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season